Stefan Larsson: Value-Based Health Care
Stefan Larsson is a senior partner and managing director in BCG’s Stockholm office. He is the global leader of BCG's Health Care Payers and Providers sector.
Stefan has been a BCG Fellow since 2010. His research topic is value-based health care—how transparency on health care outcomes and patient group costs will drive the transformation of health care systems. He has presented a TED talk on the topic, "What Doctors Can Learn from Each Other," as part of a series of talks curated by TED and BCG.
Health care costs represent 9 to 18 percent of GDP in the developed world and they have risen two to three times faster than economic growth over the past 20 years. For two decades, governments and other payers have focused on managing costs, an approach that has had limited success.
BCG is exploring a concept called value-based health care (VBHC), introduced in a 2006 book titled Redefining Health Care: Creating Value-Based Competition on Results by Michael Porter and Elizabeth Teisberg, which provides a new framework to guide effective health care reform.
Comprehensive registries of health outcomes for major patient groups are the backbone of the value-based approach. They enable clinical expert communities to convene to understand differences in performance of different providers and learn from each other—ultimately to address health care value and, for the first time, provide the platform for an alignment of strategic goals for payers, providers, and suppliers.
Stefan is also BCG's representative to a new collaboration, ICHOM (the International Consortium of Health Outcomes Measurement), cofounded jointly by BCG, Michael Porter of the Harvard Business School, and the Karolinska Institute. Stefan's relevant project experience includes the following:
Strategy, organizational redesign, and operational effectiveness for leading Nordic university hospitals and private health care provider organizations
Broad pharma experience in strategy, global sales force effectiveness, R&D effectiveness, regulatory affairs, drug safety, manufacturing, in-licensing strategy, and commercial compliance
Broad strategy experience with biotech and medtech companies across Europe as well as health care market strategy for global leaders in telecom, steel, and software
More than 50 commercial due diligence projects for leading investors seeking opportunities in health care, including private providers, pharma, medtech, and biotech
Organizational redesign for a broad range of public and private organizations, including global biotech and pharma companies
Before joining BCG, Stefan was an associate professor at the Karolinska Institute. He has published 22 articles in peer-reviewed international journals.
Stefan holds an MD from Karolinska Institute (KI) in Stockholm. He also completed his PhD studies at KI and Harvard Medical School.